Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

BACKGROUND: Detection of circulating malignant cells (CMCs) through a reverse transcriptase-polymerase chain reaction (RT-PCR) assay seems to be a demonstration of systemic disease. We here evaluated the prognostic role of RT-PCR assays in serially-taken peripheral blood samples from patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, Giuseppe, Satriano, Sabrina MR, Budroni, Mario, Cossu, Antonio, Tanda, Francesco, Canzanella, Sergio, Caracò, Corrado, Simeone, Ester, Daponte, Antonio, Mozzillo, Nicola, Comella, Giuseppe, Castello, Giuseppe, Ascierto, Paolo A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1657030/
https://www.ncbi.nlm.nih.gov/pubmed/17107608
http://dx.doi.org/10.1186/1471-2407-6-266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1657030/
https://www.ncbi.nlm.nih.gov/pubmed/17107608
http://dx.doi.org/10.1186/1471-2407-6-266

Ejemplares similares